• 

  Will Medicare Cover Aduhelm? Translating the CMS’s ‘Very Confusing’ Plan
• 

  Op-Ed: Meet Voices of Alzheimer’s—And Hear Its Founders’ Take on Aduhelm
• 

  The CMS Wants Your Input on Aduhelm Coverage—Here’s How To Comment
• 

  Why Is Everyone So Mad About Aduhelm?
• 

  Aduhelm Trial Lack of Diversity Compounded Efficacy Questions
• 

  Biogen Slashes Aduhelm Price; EMA Rejects It in EU
• 

  High Hopes, Low Sales: Aduhelm’s Dismal Roll-Out and What’s Next for Anti-Amyloids
• 

  European Drug Regulators Don’t Want to Approve Aduhelm in E.U.
• 

  Aduhelm Blamed for Jump in Next Year’s Medicare Premium
• 

  Does Aduhelm Work? Patients Weigh In on the Controversial Alzheimer’s Drug
• 

  Gantenerumab for Alzheimer’s Gets FDA ‘Breakthrough’ Status
• 

  Q&A: Marc Archambault on Support Networks In Alzheimer’s
• 

  ‘Some Hope Over No Hope:’ A Retired Doctor on Alzheimer’s Diagnosis and the Aduhelm Trial
• 

  Some Hospitals Refuse to Offer Alzheimer’s Drug Aduhelm
• 

  Medicare Is Deciding Now Whether To Cover Aduhelm—And All the Similar Drugs to Follow

Previous123Next